LifeSpeak acquires Torchlight to expand digital education to caregivers
LifeSpeak claims this is the company’s largest acquisition to date.
LifeSpeak claims this is the company’s largest acquisition to date.
Plus: How to (successfully) pivot your startup.
Nicoya’s solution helps scientists accelerate drug discovery.
In April, its solution was cleared by the U.S. Food and Drug Administration.
Toronto-based Cross-Border Impact Ventures (CBIV) has secured commitments of $30 million USD in an initial close of its new…
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using…
Whitecap Venture Partners has secured $140 million CAD for its fifth fund, which will invest in early-stage B2B SaaS and medtech…
Nomic Bio has secured a new name and $17 million USD in Series A financing to support the growth of its protein-measuring platform.…
Montréal-based healthtech startup AlayaCare has made a series of new additions to its leadership team, adding some seasoned…
Bamlanivimab, the antibody therapy discovered by Vancouver-based artificial intelligence (AI) biotech company AbCellera, has…
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using…
Spring Activator has partnered with the Telus Pollinator Fund for Good for its 2022 Investor Challenge. This iteration of the…
Tech4SickKids, a grassroots campaign to raise $25 million for Toronto’s Hospital for Sick Children (SickKids), raised $50,000…
Vancouver-based WELL Health Technologies has raised $70 million from a bought deal offering of convertible debentures. In a…
The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe. Subscribe to H|T using…